氟哌噻吨美利曲辛联合常规药物治疗对伴焦虑抑郁情绪难治性哮喘患者的疗效分析

Analysis of Flupentixol and Melitracen Combined with Conventional Medicine Therapy for Treatment of Depression and Anxiety in Patients with Refractory Asthma

目的分析氟哌噻吨美利曲辛联合常规药物治疗对伴焦虑抑郁情绪难治性哮喘患者的疗效。方法选取我院2014年2月—2017年3月收治的93例伴焦虑抑郁情绪的难治性支气管哮喘患者,随机分为观察组和对照组,对照组予常规药物治疗,观察组在对照组基础上给予氟哌噻吨美利曲辛,对比分析两组疗效。结果治疗后,两组之间的HAMA、HAMD、ACT评分、肺功能测定指标的差异有统计学意义(P<0.05),观察组各项指标明显优于对照组。结论氟哌噻吨美利曲辛联合常规药物治疗对伴焦虑抑郁情绪难治性哮喘患者具有良好的治疗效果,能够有效改善不良情绪及控制哮喘症状,值得在临床推广使用。

Objective to analyze the curative effect in the treatment of depression and anxiety in patients with refractory asthma Flupentixol and melitracen combined with conventional medicine. Methods in our hospital from February 2014 to March 2017 were 93 patients with anxiety and depression of patients with refractory asthma,were randomly divided into observation group and control group,control group was treated with routine drug treatment,the observation group in the control group were given Deanxit,comparative analysis of two groups. Results after treatment between the two groups HAMA,HAMD,ACT score,there were statistically significant differences in lung function index(P<0.05),the indicators of the observation group was significantly better than the control group. Conclusion flupentixol and melitracen combined with routine medication in the treatment of depression and anxiety in patients with refractory asthma has a good therapeutic effect,can effectively improve the negative emotion and control asthma symptoms in clinical value The bed is popularized.